Changzhou KansenBio Technology Co., Ltd

Founded in 2022, KansenBio is backed by the transformation of scientific and technological achievements from Tsinghua University and focuses on the R&D and industrialization of biotechnology and bio-based raw materials. Built around its core biological technology platform, the company has completed laboratory-scale trials, pilot-scale trials and large-scale verification of multiple products, and achieved 100-ton level industrial production in 2025. The company has systematically laid out its business around various bioactive molecules and developed a diversified product pipeline. While improving its intellectual property and quality management systems, it has secured numerous domestic and international patents as well as international certifications.